Neurocrine Biosciences Inc. (NBIX)
NASDAQ · Healthcare
Neurocrine Biosciences Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 2.86B | 2.36B | 1.89B | 1.49B | 1.13B | 1.05B | 788.1M | 451.2M | 161.6M | 15.0M | 19.8M | 0 | 2.9M | 53.1M | 77.4M | 33.5M | 3.0M |
| Gross Profit | 2.81B | 2.32B | 1.85B | 1.47B | 1.12B | 1.04B | — | 446.3M | 160.4M | 15.0M | 19.8M | — | — | — | — | — | — |
| Profitability | |||||||||||||||||
| Operating Income | 619.1M | 570.5M | 250.9M | 249.0M | 102.5M | 163.0M | 72.3M | 36.8M | -131.4M | -147.4M | -94.2M | -64.4M | -49.7M | 1.4M | 33.9M | -13.7M | -53.7M |
| EBITDA | — | — | — | — | — | — | — | 40.8M | -129.0M | -145.9M | -93.2M | -63.6M | -49.0M | 2.1M | 34.6M | -12.3M | -50.5M |
| Net Income | 478.6M | 341.3M | 249.7M | 154.5M | 89.6M | 407.3M | 37.0M | 21.1M | -142.5M | -141.1M | -88.9M | -60.5M | -46.1M | 5.0M | 37.6M | -8.0M | -51.0M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 103M | 104M | 101M | 99M | 98M | 98M | 96M | 95M | 88M | 87M | 84M | 75M | 67M | 67M | 56M | 53M | 39M |
Neurocrine Biosciences Inc. Income Statement — FAQ
Neurocrine Biosciences Inc. (NBIX) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NBIX's income statement history?
The chart and table above show Neurocrine Biosciences Inc.'s income statement by year and by quarter, including the growth rate.